Nausea, vomiting, and retching: Complex problems in palliative care

Ca-A Cancer Journal for Clinicians

Volumn 51, Issue 4, 2001, Pages 232-248

  Rhodes, Verna A ^a   McDaniel, Roxanne W ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CANNABINOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CORTICOSTEROID; DEXAMETHASONE; DIGOXIN; DOLASETRON MESILATE; DRONABINOL; DROPERIDOL; GRANISETRON; HALOPERIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; LORAZEPAM; METOCLOPRAMIDE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OPIATE; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; THIETHYLPERAZINE; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

ACUPRESSURE; ACUPUNCTURE; ADULT; ADVANCED CANCER; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORECEPTOR; COMORBIDITY; CONTROLLED STUDY; DIET THERAPY; DROWSINESS; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENDER; HUMAN; HYPOTENSION; MALE; MEDICAL ASSESSMENT; MUSCLE RELAXATION; MUSIC THERAPY; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; SELF REPORT; SYMPTOM;

EID: 0034916733     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.51.4.232     Document Type: Article

References (101)

1. Symptom control during the last week of life
2. Dying from cancer: Results of a national population-based investigation
3. Guidelines for the optimal management of chemotherapy-induced nausea and vomiting: A consensus
4. Chronic nausea in advanced cancer patients: A retrospective assessment of a metoclopramide-based anti-emetic regimen
5. Concordance of cancer patient and caregiver symptom reports
6. Progress in reducing anticipatory nausea and vomiting
7. Effect of post-chemotherapy nausea and vomiting on health-related quality of life
8. Nausea and vomiting, quality of life, and the oncology nurse
9. Palliative care: Past, present and future perspectives
10. Palliative nursing care of a man with terminal cancer
11. The art of palliative care: Living with hope, dying with dignity
12. Patterns of nausea, vomiting and distress in patients receiving antineoplastic drug protocols
13. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zogran), granisetron (Kytril), and tropisetron (Navoban)
14. Measuring nausea, vomiting, and retching
15. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life
16. Plasma morphine glucuronide (M3G and M6G) concentations in hospice inpatients
17. Dehydration symptoms of palliative care cancer patients
18. Use of ondansetron in palliative medicine
19. Do outcomes meet expectations in patients undergoing palliative chemotherapy for advanced ovarian cancer?
20. Prevention of radiotherapy-induced emesis
21. Symptom distress - The concept; past and present
22. Symptom experience: The management of symptom occurrence and symptom distress
23. Patient education
24. Expectation and occurrence of postchemotherapy side effects: Nausea and vomiting
25. Development of a symptom distress scale
26. A model for symptom management
27. Development of reliable and valid measures of nausea and vomiting
28. Differences in nausea, vomiting and retching between younger and older outpatients receiving cancer chemotherapy
29. Nausea and Vomiting
30. Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds
31. 5-HT3 receptors and cytotoxic drug-induced vomiting
32. Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin
33. Antiemetic research: A look to the future
34. Antiemetic Therapy
35. Development of a preparatory sensory information video tape for women receiving chemotherapy for breast cancer
36. Sensory perception of patients on selected anti-neoplastic chemotherapy protocols
37. Laboratory and field experimentation: Development of a theory of self-regulation
38. The effects of nursing care guided by self regulation theory on coping with radiation therapy
39. Process of coping with radiation
40. Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles
41. Prevalence, predictors, and course of anticipatory nausea in women receiving chemotherapy for breast cancer
42. The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: A review and synthesis
43. Anticipatory nausea and vomiting in cancer patients
44. Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability
45. Cardiovascular conditioning and anticipatory nausea and vomiting in cancer patients
46. Chemotherapy of metastatic breast cancer in the elderly: The Piedmont Oncology Association experience
47. The development and management of chemotherapy related anticipatory nausea and vomiting
48. Nausea and vomiting of pregnancy
49. Postoperative nausea and vomiting: Development of a management protocol
50. Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness
51. The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting
52. Evaluation of ethanol as an antiemetic in patients receiving cisplatin
53. An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting
54. The relationship of nausea and dyspnea to pain in seriously ill patients
55. The course of symptom frequency and intensity in advanced cancer patients followed at home
56. Palliation of nausea and vomiting
57. Impact of tumour burden on chemotherapy induced nausea and vomiting
58. Comparison of the efficacy, safety and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer
59. Issues in the measurement of nausea
60. The Index of nausea, vomiting, and retching: A new format of the Index of Nausea, Vomiting
61. Relaxation training for control of nausea and vomiting in patients receiving chemotherapy
62. Hospice patient and nurses' perceptions of selfcare deficits based on symptom experience
63. An instrument to measure symptom experience. Symptom occurrence and symptom distress
64. The memorial symptom assessment scale: An instrument for the evaluation of symptom prevalence, characteristics and distress
65. Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes
66. The delayed-emesis syndrome from cisplatin: Phase III evaluation of ondansetron versus placebo
67. Nausea and vomiting
68. Gastrointestinal toxicity of chemotherapeutic agents
69. Comparison of prochlorperazine and lorazepam antiemetic regimens in the control of postchemotherapy symptoms
70. Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasone
71. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer
72. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy
73. Marijuana as an antiemetic drug: How useful is it today? Opinions from clinical oncologists
74. Management of chemotherapy-induced nausea and vomiting
75. The ethics of medical marijuana: Government restrictions vs. medical necessity
76. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relived by tetrahydrocannabinol (dronabinol)
77. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery
78. Taste changes experienced by patients receiving chemotherapy
79. Quality of life is the most important goal of nutritional support of the dying
80. Acupuncture
81. Acupressure treatment for prevention of postoperative nausea and vomiting
82. Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section
83. Alternative therapies for nausea and vomiting of pregnancy
84. Prolongation of the antiemetic action of p6 acupuncture by acupressure in patients having cancer chemotherapy
85. Acupuncture prophylaxis of cancer chemotherapy-induced sickness
86. Acupressure for nausea: Results of a pilot study
87. Acupressure wrist bands to relieve nausea and vomiting in hospice patients: Do they work?
88. The effects of music therapy and guided visual imagery on chemotherapy induced nausea and vomiting
89. Music as an adjunct to antiemetic therapy
90. Relaxation Techniques: An adjunct therapy for cancer patients
91. Progressive muscle relaxation as antiemetic therapy for cancer patients
92. Behavioral treatment of chemotherapy-induced nausea and vomiting
93. Efficacy of relaxation training (RT) and guided imagery (GI) in reducing the side effects of cancer chemotherapy
94. Relaxation to reduce nausea, vomiting and anxiety induced by chemotherapy in Japanese patients
95. Comparative trial of clinical relaxation and an antiemetic drug regimen in reducing chemotherapy-related nausea and vomiting
96. The influence of guided imagery on chemotherapy-related nausea and vomiting
97. Anorexia and cachexia in advanced cancer patients